Zydus and MSN Launch First Generic Riociguat in the US
MM Desk
19 October, 2026
Zydus Lifesciences Limited, in partnership with MSN Laboratories Private Limited, has launched the first generic
Zydus Lifesciences Limited, in partnership with MSN Laboratories Private Limited, has launched the first generic
Zydus Lifesciences Limited has announced the launch of its Semaglutide injection in India under the
Zydus Lifesciences Limited has announced that its innovative drug, Desidustat, has received approval from China’s
Zydus Lifesciences Limited has introduced a new set of companion diagnostic solutions aimed at improving
Zydus Lifesciences Limited has launched the world’s first biosimilar of Nivolumab in India under the
Sentynl Therapeutics Inc, a US-based biopharmaceutical company wholly owned by Zydus Lifesciences Limited, has received
Zydus Lifesciences Limited, an innovation-focused life sciences company with a global presence, has signed an
Zydus Lifesciences Ltd announced today an exclusive licensing and supply agreement with MSN Laboratories for
In a significant development, Zydus Lifesciences Ltd announced on Thursday that it has secured final
In a significant development, Zydus Lifesciences Ltd announced on Thursday that it has secured final